Red Tortoise LLC’s Day One Biopharmaceuticals DAWN Stock Holding History

Red Tortoise LLC’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-216	Closed	-$2.74K	–	599
2024 Q4	$2.74K	Buy	216 +20	+10%	+$278	﹤0.01%	465
2024 Q3	$2.73K	Hold	196	–	–	﹤0.01%	468
2024 Q2	$2.7K	Hold	196	–	–	﹤0.01%	459
2024 Q1	$3.24K	Hold	196	–	–	﹤0.01%	422
2023 Q4	$2.86K	Hold	196	–	–	﹤0.01%	394
2023 Q3	$2.4K	Hold	196	–	–	﹤0.01%	407
2023 Q2	$2.34K	Hold	196	–	–	﹤0.01%	428
2023 Q1	$2.62K	Hold	196	–	–	﹤0.01%	388
2022 Q4	$4.22K	Buy	+196	New	+$4.02K	﹤0.01%	343
2021 Q4	–	Sell	-196	Closed	-$4K	–	177
2021 Q3	$4K	Buy	+196	New	+$4.7K	﹤0.01%	315

Other funds holding DAWN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

ECM

Estuary Capital Management Wayzata, Minnesota $598M AUM 1.72% 1-Year Est. Return

Red Tortoise LLC's DAWN Position: Q1 2025 in Review

Red Tortoise LLC sold out of Day One Biopharmaceuticals (DAWN) in Q1 2025, closing a stake of 216 shares — an estimated $2.74K sold.

Red Tortoise LLC first reported a position in DAWN in Q3 2021 and held it in 10 quarters. The position peaked at $4.22K in Q4 2022. 184 funds tracked by Wall St. Rank hold DAWN as of Q1 2025.

Red Tortoise LLC reported no remaining Day One Biopharmaceuticals position as of Q1 2025 after selling out during the quarter.
Red Tortoise LLC sold 216 Day One Biopharmaceuticals shares in Q1 2025, an estimated $2.74K.
Red Tortoise LLC first reported a position in Day One Biopharmaceuticals in Q3 2021 and held it in 10 quarters.
Red Tortoise LLC's Day One Biopharmaceuticals position peaked at $4.22K in Q4 2022.
184 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2025.

Based on Red Tortoise LLC's 13F filing for Q1 2025, filed 25 Apr 2025.